These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38015959)
1. Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice. Bosman M; Krüger DN; Favere K; De Meyer GRY; Franssen C; Van Craenenbroeck EM; Guns PJ PLoS One; 2023; 18(11):e0294848. PubMed ID: 38015959 [TBL] [Abstract][Full Text] [Related]
2. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury. Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580 [TBL] [Abstract][Full Text] [Related]
3. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity. Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin induces arterial stiffness: A comprehensive in vivo and ex vivo evaluation of vascular toxicity in mice. Bosman M; Favere K; Neutel CHG; Jacobs G; De Meyer GRY; Martinet W; Van Craenenbroeck EM; Guns PDF Toxicol Lett; 2021 Aug; 346():23-33. PubMed ID: 33895255 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity. Bosman M; Krüger DN; Favere K; Wesley CD; Neutel CHG; Van Asbroeck B; Diebels OR; Faes B; Schenk TJ; Martinet W; De Meyer GRY; Van Craenenbroeck EM; Guns PDF Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884612 [TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice. Kropp J; Roti Roti EC; Ringelstetter A; Khatib H; Abbott DH; Salih SM PLoS One; 2015; 10(11):e0142588. PubMed ID: 26544188 [TBL] [Abstract][Full Text] [Related]
8. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p. Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669 [TBL] [Abstract][Full Text] [Related]
9. Water Extract of Jeong Y; Lee SH; Lee J; Kim MS; Lee YG; Hwang JT; Choi SY; Yoon HG; Lim TG; Lee SH; Choi HK Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958893 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers. Bosman M; Krüger D; Van Assche C; Boen H; Neutel C; Favere K; Franssen C; Martinet W; Roth L; De Meyer GRY; Cillero-Pastor B; Delrue L; Heggermont W; Van Craenenbroeck EM; Guns PJ Cardiovasc Res; 2023 Nov; 119(15):2579-2590. PubMed ID: 37625456 [TBL] [Abstract][Full Text] [Related]
11. The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent Dexrazoxane. Hasinoff BB; Patel D; Wu X Cardiovasc Toxicol; 2020 Jun; 20(3):312-320. PubMed ID: 31773441 [TBL] [Abstract][Full Text] [Related]
13. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress. Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254 [TBL] [Abstract][Full Text] [Related]
14. Aspalathin ameliorates doxorubicin-induced oxidative stress in H9c2 cardiomyoblasts. Shabalala SC; Dludla PV; Muller CJF; Nxele X; Kappo AP; Louw J; Johnson R Toxicol In Vitro; 2019 Mar; 55():134-139. PubMed ID: 30576852 [TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity. Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266 [TBL] [Abstract][Full Text] [Related]
17. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity. Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253 [TBL] [Abstract][Full Text] [Related]
18. Sodium thiosulfate prevents doxorubicin-induced DNA damage and apoptosis in cardiomyocytes in mice. Mizuta Y; Tokuda K; Guo J; Zhang S; Narahara S; Kawano T; Murata M; Yamaura K; Hoka S; Hashizume M; Akahoshi T Life Sci; 2020 Sep; 257():118074. PubMed ID: 32673667 [TBL] [Abstract][Full Text] [Related]
19. BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function. Gyongyosi A; Csaki N; Peto A; Szoke K; Fenyvesi F; Bacskay I; Lekli I Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982341 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells. Rharass T; Gbankoto A; Canal C; Kurşunluoğlu G; Bijoux A; Panáková D; Ribou AC Mol Cell Biochem; 2016 Feb; 413(1-2):199-215. PubMed ID: 26833193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]